Pulmonary complications of sickle cell anemia: A need for increased recognition, treatment, and research

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 11, 2001, Pages 2016-2019

  Minter, Karin R ^a,b   Gladwin, Mark T ^a,b,c  

^a Clinical Center   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ACUTE CHEST SYNDROME; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; FORCED EXPIRATORY VOLUME; LUNG COMPLICATION; LUNG FIBROSIS; MORTALITY; NEGRO; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; REVIEW; SICKLE CELL ANEMIA; THORAX RADIOGRAPHY; THROMBOEMBOLISM;

EID: 0035665831     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.11.2104101     Document Type: Review

References (62)

1. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial
2. Mortality in sickle cell disease. Life expectancy and risk factors for early death
3. Mortality among children with sickle cell disease identified by newborn screening during 1990-1994 - California, Illinois, and New York
4. Preventing morbidity and mortality from sickle cell disease. A public health perspective
5. Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review
6. Patterns of mortality in sickle cell disease in the United Kingdom
7. Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure
8. Causes of death in sickle-cell disease in Jamaica
9. Pulmonary function in sickle cell disease with or without acute chest syndrome
10. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease
11. Thoracic manifestations of sickle cell disease
12. Scintigraphic evidence of pulmonary vascular occlusion in sickle cell disease
13. Acute chest syndrome in sickle cell disease: Clinical presentation and course. Cooperative Study of Sickle Cell Disease
14. Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemia
15. Role of coagulation system in pathophysiology of sickle cell disease
16. Factor-8 (antihaemophilic factor) activity in sickle-cell anaemia
17. Tissue factor expression by endothelial cells in sickle cell anemia
18. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
19. Causes and outcomes of the acute chest syndrome in sickle cell disease
20. Acute chest syndrome of sickle cell disease: New light on an old problem
21. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome
22. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease
23. Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia
24. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: Value for diagnostic assessment of fat embolism
25. Rib infarcts and acute chest syndrome in sickle cell diseases
26. Severe hypoxemia secondary to acute sternal infarction in sickle cell anemia
27. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases
28. The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment
29. Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia
30. Cardiorespiratory adjustments in chronic sickle cell anemia
31. Lung function in sickle cell hemoglobinopathy patients compared with healthy subjects
32. Lung function in infants with sickle cell disease
33. Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity
34. Occlusive pulmonary vascular disease associated with hemoglobin SC disease. A case report
35. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies
36. Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia
37. Pulmonary hypertension and sickle hemoglobinopathy
38. Left ventricular filling pressure in sickle cell anemia
39. Maternal death due to sickle cell chronic lung disease
40. Pulmonary hypertension in sickle cell disease
41. Systemic fat embolism and pulmonary hypertension in sickle cell disease
42. Weekly clinicopathological exercises. Case 52-1983. Pulmonary hypertension associated with abnormal hemoglobin
43. Prostacyclin for secondary pulmonary hypertension
44. Pulmonary hypertension in sickle cell disease
45. Pulmonary changes in sickle cell disease
46. The lung in sickle cell disease
47. Cardiopulmonary assessment in beta-thalassemia major
48. Pulmonary hypertension in patients with thalassemia major
49. The heart of the patient with beta thalassemia major. Study with magnetic resonance
50. Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia
51. Cardiac involvement in thalassemia intermedia: A multicenter study
52. Hydroxyl radical formation by sickle erythrocyte membranes: Role of pathologic iron deposits and cytoplasmic reducing agents
53. Nonheme iron in sickle erythrocyte membranes: Association with phospholipids and potential role in lipid peroxidation
54. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin
55. Spontaneous oxygen radical generation by sickle erythrocytes
56. Pulmonary hypertension associated with long-standing thrombocytosis
57. Pathogenesis and treatment of sickle cell disease
58. Sickle cell anemia as an inflammatory disease
59. The acute chest syndrome of sickle cell disease
60. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
61. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults
62. Pharmacologic induction of fetal hemoglobin: Raising the therapeutic bar in sickle cell disease